The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
Dr Harry Al-Wassiti, Research Fellow at the Monash Institute of Pharmaceutical Sciences (MIPS), answers the questions about the jab that's on everyone's mind.
Unprecedented efforts are driving the global push for a safe and effective COVID-19 vaccine. Here's how it's likely to be rolled out in Australia.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
Dr Harry Al-Wassiti is now part of a Monash research team striving to find a COVID-19 vaccine, but his path has been far from easy.
How likely is it that we'll have a relatively quick fix for COVID-19, and what are the hurdles?
Dummy text
